Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney loop of Henle epithelial cell | 6 studies | 28% ± 10% | |
renal alpha-intercalated cell | 5 studies | 46% ± 23% | |
ionocyte | 4 studies | 28% ± 10% | |
kidney distal convoluted tubule epithelial cell | 4 studies | 40% ± 10% |
Insufficient scRNA-seq data for expression of CLCNKA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 4003.20 | 653 / 653 | 44% | 4.60 | 269 / 605 |
kidney | 100% | 11052.37 | 89 / 89 | 42% | 10.97 | 378 / 901 |
adrenal gland | 96% | 466.67 | 247 / 258 | 38% | 5.77 | 88 / 230 |
ovary | 85% | 145.84 | 153 / 180 | 41% | 1.25 | 176 / 430 |
pancreas | 99% | 313.23 | 326 / 328 | 17% | 0.38 | 31 / 178 |
prostate | 83% | 138.66 | 203 / 245 | 32% | 0.59 | 159 / 502 |
uterus | 85% | 171.87 | 145 / 170 | 14% | 0.40 | 64 / 459 |
stomach | 90% | 403.62 | 322 / 359 | 6% | 0.12 | 18 / 286 |
breast | 66% | 153.18 | 302 / 459 | 27% | 0.59 | 298 / 1118 |
eye | 0% | 0 | 0 / 0 | 85% | 4.37 | 68 / 80 |
skin | 40% | 83.52 | 731 / 1809 | 11% | 0.48 | 52 / 472 |
blood vessel | 51% | 62.67 | 676 / 1335 | 0% | 0 | 0 / 0 |
lung | 34% | 40.84 | 197 / 578 | 15% | 0.48 | 175 / 1155 |
adipose | 44% | 68.26 | 532 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 34% | 50.69 | 494 / 1445 | 7% | 0.20 | 12 / 183 |
intestine | 31% | 36.87 | 300 / 966 | 3% | 0.09 | 15 / 527 |
muscle | 33% | 43.65 | 263 / 803 | 0% | 0 | 0 / 0 |
liver | 8% | 9.63 | 18 / 226 | 22% | 0.75 | 90 / 406 |
brain | 21% | 184.70 | 560 / 2642 | 4% | 0.06 | 25 / 705 |
heart | 23% | 24.12 | 202 / 861 | 0% | 0 | 0 / 0 |
bladder | 10% | 8.38 | 2 / 21 | 6% | 0.26 | 28 / 504 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.51 | 4 / 29 |
spleen | 6% | 5.93 | 14 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 4% | 4.33 | 37 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070293 | Biological process | renal absorption |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0030321 | Biological process | transepithelial chloride transport |
GO_0006821 | Biological process | chloride transport |
GO_0034707 | Cellular component | chloride channel complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0042802 | Molecular function | identical protein binding |
GO_0005247 | Molecular function | voltage-gated chloride channel activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CLCNKA |
Protein name | Chloride channel protein ClC-Ka (Chloride channel Ka) (ClC-K1) |
Synonyms | |
Description | FUNCTION: Voltage-gated chloride channel. Chloride channels have several functions including the regulation of cell volume; membrane potential stabilization, signal transduction and transepithelial transport. May be important in urinary concentrating mechanisms. |
Accessions | ENST00000375692.5 [P51800-3] ENST00000439316.6 [P51800-2] ENST00000331433.5 [P51800-1] P51800 |